1. Home
  2. AIT vs RGEN Comparison

AIT vs RGEN Comparison

Compare AIT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIT
  • RGEN
  • Stock Information
  • Founded
  • AIT 1923
  • RGEN 1981
  • Country
  • AIT United States
  • RGEN United States
  • Employees
  • AIT N/A
  • RGEN N/A
  • Industry
  • AIT Industrial Machinery/Components
  • RGEN Medical/Dental Instruments
  • Sector
  • AIT Industrials
  • RGEN Health Care
  • Exchange
  • AIT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AIT 9.8B
  • RGEN 8.2B
  • IPO Year
  • AIT N/A
  • RGEN N/A
  • Fundamental
  • Price
  • AIT $244.12
  • RGEN $154.00
  • Analyst Decision
  • AIT Buy
  • RGEN Buy
  • Analyst Count
  • AIT 6
  • RGEN 11
  • Target Price
  • AIT $291.00
  • RGEN $170.90
  • AVG Volume (30 Days)
  • AIT 278.5K
  • RGEN 1.1M
  • Earning Date
  • AIT 10-28-2025
  • RGEN 10-28-2025
  • Dividend Yield
  • AIT 0.74%
  • RGEN N/A
  • EPS Growth
  • AIT 6.01
  • RGEN N/A
  • EPS
  • AIT 10.39
  • RGEN 0.03
  • Revenue
  • AIT $4,664,003,000.00
  • RGEN $707,890,000.00
  • Revenue This Year
  • AIT $7.55
  • RGEN $17.50
  • Revenue Next Year
  • AIT $5.30
  • RGEN $12.74
  • P/E Ratio
  • AIT $23.96
  • RGEN $4,935.00
  • Revenue Growth
  • AIT 4.03
  • RGEN 11.74
  • 52 Week Low
  • AIT $199.96
  • RGEN $102.97
  • 52 Week High
  • AIT $282.98
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • AIT 36.09
  • RGEN 55.39
  • Support Level
  • AIT $255.14
  • RGEN $144.81
  • Resistance Level
  • AIT $260.51
  • RGEN $158.74
  • Average True Range (ATR)
  • AIT 6.49
  • RGEN 6.62
  • MACD
  • AIT -1.11
  • RGEN -0.31
  • Stochastic Oscillator
  • AIT 2.86
  • RGEN 75.28

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: